<DOC>
	<DOCNO>NCT02516501</DOCNO>
	<brief_summary>Type study : Pilot / phase I trial Study purpose To assess impact dietary intervention radio ( chemo ) therapy ( RCT ) body composition change Trial Treatment Patients split control group intervention group 1 . If willing undertake ketogenic diet duration radiotherapy , patient enter intervention group 2 . - Group 1 : On irradiation day irradiation overnight fast + ketogenic breakfast consist 50-250 ml betaquick® ( vitaflo , Bad Homburg , Germany ) 5-15 g Master Amino Acid Pattern ( dr. reinwald healthcare gmbh+co kg , Schwarzenbruck , Germany ) . - Group 2 : Complete ketogenic diet plus 5-15g Master Amino Acid Pattern/day - Control : No dietary intervention . - All group : Weight measurement bioimpedance analysis ( BIA ) per week , routine blood parameter quality life ( QoL ) questionnaire , RCT Endpoints Primary : - Feasibility dietary intervention RCT , measure dropout rate - Changes body weight - BIA phase angle quantity derive BIA variable Secondary : - QoL - Toxicities - Blood parameter - Grade regression time surgery case rectum carcinoma Inclusion criterion - One follow tumor entity : - Breast carcinoma - Rectum carcinoma - Head &amp; Neck Cancer - Histological confirmation malignancy - Signed write informed consent - Karnofsky index ≥ 70 - Age 18 75 year - BMI 18 34 kg/m^2 Exclusion criterion - Palliative patient , particular metastasis - Type I diabetes - Pregnancy - Pacemaker metallic part within body - Known defect enzymes necessary ketogenesis , ketolysis , fatty acid oxidation gluconeogenesis - Unable speak understand German - Cognitive impairment psychological disorder - Renal insufficiency Planned accrual - 15 patient colorectal mammary tumor plus 5 patient H &amp; N cancer intervention group 1 - 15 patient colorectal mammary tumor plus 5 patient H &amp; N cancer control group - Minimum 5 patient tumor entity intervantion group 2 Total : n ≥ 85 patient Study procedure 1 . Inclusion full write informed consent . 2 . Baseline BIA measurement blood work 3 . RCT weekly BIA assessment ; least one blood withdrawal ± concurrent dietary intervention 4 . Final BIA measurement blood work radiotherapy Follow For rectal carcinoma : Regression time surgery ( c p )</brief_summary>
	<brief_title>Impact Ketogenic Diet Intervention During Radiotherapy Body Composition</brief_title>
	<detailed_description />
	<criteria>RT one follow tumor entity : Mammary carcinoma , colorectal carcinoma , head neck carcinoma Histologicallý confirm malignant Tumor Written inform consent Karnofsky index &gt; = 70 18 kg/m^2 &lt; BMI &lt; 34 kg/m^2 Palliative Treatment Type I Diabetes Pregnancy Pacemaker othe rmetallic part make BIA prediction unreliable Unable understand speak German Cognitive impairment Renal insufficiency intake carboanhydraseinhibitors Rare metabolic disorder speak ketogenic diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Ketogenic Diet</keyword>
	<keyword>Body composition</keyword>
	<keyword>Radiation therapy</keyword>
</DOC>